ArticleMolecular pharmacology2020

Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.

Xiaolei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.